FBRX icon

Forte Biosciences
FBRX

Overview Fund Activity

57 hedge funds and large institutions have $65.6M invested in Forte Biosciences in 2017 Q4 according to their latest regulatory filings, with 20 funds opening new positions, 28 increasing their positions, 6 reducing their positions, and 7 closing their positions.

New
Increased
Maintained
Reduced
Closed
Holders
57
Holders Change
+13
Holders Change %
+29.55%
% of All Funds
1.29%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
20
Increased
28
Reduced
6
Closed
7
Calls
$331K
Puts
$425K
Net Calls
-$94K
Net Calls Change
-$94K

Top Buyers

1
BlackRock
BlackRock
New York
$11M
2
Vanguard Group
Vanguard Group
Pennsylvania
$6.64M
3
BCM
Bridgeway Capital Management
Texas
$1.03M
4
AG
Artal Group
Luxembourg
$1.03M
5
Northern Trust
Northern Trust
Illinois
$1.96M

Top Sellers

1
EC
EcoR1 Capital
California
$0
2
BI
BVF Inc
California
$5.71M
3
ACP
Acuta Capital Partners
California
$0
4
FCMI
Foresite Capital Management III
California
$1.52M
5
MIM
Monashee Investment Management
Massachusetts
$0
Name Holding Trade Value Shares
Change 		Shares
Change %
Citigroup
51
Citigroup
New York
$26K +$26K +7 New
SO
52
STRS Ohio
Ohio
$25K – – –
AIP
53
Ameritas Investment Partners
Nebraska
$16K +$8K +2 +100%
Carson Wealth (CWM LLC)
54
Carson Wealth (CWM LLC)
Nebraska
$10K – – –
AG
55
Advisor Group
Arizona
$10K +$10K +3 New
Simplex Trading
56
Simplex Trading
Illinois
$9K +$9K +2 New
IP
57
Isthmus Partners
Wisconsin
$5K – – –
EC
58
EcoR1 Capital
California
– -$18.7M -4,006 Closed
ACP
59
Acuta Capital Partners
California
– -$3.13M -670 Closed
NIP
60
Nicholas Investment Partners
California
– -$623K -133 Closed
AC
61
Ascend Capital
California
– -$464K -99 Closed
NFA
62
Nationwide Fund Advisors
Ohio
– -$59K -13 Closed
TRCT
63
Tower Research Capital (TRC)
New York
– -$24K -5 Closed
UBS Group
64
UBS Group
Switzerland
– -$3K -1 Closed
MIM
65
Monashee Investment Management
Massachusetts
– -$950K – –
1 2
3